Executive Director and Chairperson | Imunexus Therapeutics (Pre-IPO)
Philippa Lewis
Philippa Lewis is a Professional Company Director, Chairperson and Chief Executive with expertise in the Medtech, Biotech, Digital and Artificial Intelligence sectors.Philippa has extensive global, commercial and corporate engagement with demonstrated success. Founding over ten start-ups she has led local and North American IPOs, reverse mergers, complex M&A transactions, strategic capital management and multilateral joint ventures within North America, Europe, China and Australia. She was nominated as Zurich Business Leader of the Year and Telstra Business Woman of the Year and is currently an official company mentor for the Australian Technology Competition as well as an appointed grants assessor for the NSW Government Medtech and Pharma Growth Centre. Philippa is a Graduate of the Australian Institute of Company Directors, The Institute of Public Companies Canada via Simon Fraser University, and The Adelaide University in respect of Legal Arbitration and is a member of the Australian Institute of Company Directors, The MTAA, The Institute of Arbitrators and Mediators and The Resolution Institute.
Speciality
Executive Director and Chairperson | Imunexus Therapeutics (Pre-IPO)
Personal info
Imunexus Therapeutics (Pre-IPO)
Join us for an exclusive investor presentation with Imunexus, a company redefining how next‑generation biologics are created. Imunexus has developed a powerful platform that transforms existing biologic drugs into bispecific therapeutics, unlocking new mechanisms of action, accelerating development timelines, and reducing risk by building on proven molecules.
This live session will showcase how Imunexus’ technology expands the commercial and clinical potential of established drugs, the market opportunities it opens, and the company’s path to value creation.
If you’re looking for breakthrough innovation with a de‑risked development model, this is a presentation you won’t want to miss.
